The research compared 35 studies that tracked men and women’s persistent COVID-19 symptoms between December 2019 and May 31, 2021, before vaccines were widely available.
Of the 1,393,355 study participants, female patients were more likely than male patients to experience depression; ear, nose, or throat; musculoskeletal; and respiratory symptoms. Men were more likely to experience acute kidney injury.
Women also were more likely to have dermatological, gastrointestinal and neurological long COVID-19 symptoms.
The article’s authors wrote that “the size of female cohorts and sex-disaggregated data analysis and reporting are insufficient in medical research” and said further studies tracking long COVID-19 should report differences among sexes.
Researchers are continuing to evaluate the potential causes of long COVID-19, including probes into the possibility of a perpetual virus, blood vessel damage and the immune system struggling to bounce back.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
